Which T1 lung cancers require "radical therapy"?
- VernacularTitle:哪些 T1 期肺癌需要我们“激进治疗”？
- Author:
Wensong SHI
1
,
2
,
3
;
Yuzhui HU
4
;
Guotao CHANG
1
,
2
,
3
;
Yanjie ZENG
1
,
2
,
3
;
Yulun YANG
1
,
2
,
3
;
Xiaogang ZHAO
5
Author Information
1. Department of Thoracic Surgery, People&rsquo
2. s Hospital of Zhengzhou, People&rsquo
3. s Hospital of Henan University of Chinese Medicine, Zhengzhou, 450000, P.R.China
4. Department of Respiratory Medicine, Affiliated Hospital of Guilin Medical University, Guilin, 541000, Guangxi, P.R.China
5. Department of Thoracic Surgery, Shanghai Pulmonary Hospital Affiliated to Tongji University, Shanghai, 200433, P.R.China
- Publication Type:Journal Article
- Keywords:
Stage T1 lung cancer;
invasiveness;
radical therapy;
review
- From:
Chinese Journal of Clinical Thoracic and Cardiovascular Surgery
2020;27(08):965-971
- CountryChina
- Language:Chinese
-
Abstract:
Stage T1 lung cancer refers to the tumor with maximum diameter≤3 cm, surrounded by the pleural membrane of the lung or viscera, and does not exceed the lobar bronchus under the bronchoscope. The prognosis is generally good, but some of them are more invasive, and more aggressive treatments are needed to achieve the best prognosis. This article reviews which T1 lung cancers are susceptible to metastasis and their risk factors. It is hoped that such patients will receive the attention of relevant scholars, and when they are encountered clinically, a more aggressive approach will be taken to extend their life expectancy．
